Pharmacosmos has provided an educational grant to the Cardiorenal Forum (Secretariat, Concise Clinical Consulting) to support the costs of running this webinar and has had no influence over the content or selection of speakers for the programme
What is the webinar about?
This is the second in our Masterclass series looking at the clinical use of intravenous (iv) iron. The focus of this Masterclass is on its use in the patient with cardiorenal disease, particularly chronic kidney disease (CKD). Iron deficiency anaemia is a common complication of CKD and is associated with an increased risk of morbidity and mortality. The mortality may be related to the severity of anaemia.
So it is important that we accurately diagnose iron deficiency in our cardiorenal patients and optimally treat it. This Masterclass looks at newer intravenous iron products, their benefits and role in this patient population.
Learning objectives
Is it for me?
This webinar is for healthcare professionals. It is aimed particularly at trainees treating cardiorenal patients particularly those working in nephrology, care of the elderly, general medicine, general practitioners, clinical pharmacists and allied disciplines. There will also be relevance for those working in cardiology.
Dr Caroline Evans |
|
Dr Matthew Graham-Brown |
|
Professor Paul Kalra |
Professor Philip Kalra |
|
Ms Sue Scott |
|
Professor Myles Wolf |
Funding
Pharmacosmos has provided an educational grant to the Cardiorenal Forum (Secretariat, Concise Clinical Consulting) to support the costs of running this webinar and has had no influence over the content or selection of speakers for the programme.